IGF-I promotes a shift in metabolic flux in vascular smooth muscle cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 283, Issue 3 46-3, 2002, Pages

  Hall, Jennifer L ^a,d   Gibbons, Gary H ^b   Chatham, John C ^c  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Division of Cardiology   (United States)

Author keywords

Anaplerosis; Glucose; Glucose transporter 1; Insulin like growth factor I; Vascular smooth muscle

Indexed keywords

GLUCOSE TRANSPORTER 1; SOMATOMEDIN C;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CITRIC ACID CYCLE; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOLYSIS; METABOLIC REGULATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0036711095     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00072.2002     Document Type: Article

References (50)

1. 13C isotopomer analysis of glutamate. Am J Physiol Heart Circ Physiol 275: H2227-H2235, 1998.
2. Bai HZ, Pollman MJ, Inishi Y, and Gibbons GH. Regulation of vascular smooth muscle cell apoptosis. Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway. Circ Res 85: 229-237, 1999.
3. Barron JT, Kopp SJ, Tow JP, and Parrillo JE. Differential effects of fatty acids on glycolysis and glycogen metabolism in vascular smooth muscle. Biochim Biophys Acta 1093: 125-134, 1991.
4. Barron JT, Kopp SJ, Tow J, and Parrillo JE. Fatty acid, tricarboxylic acid cycle metabolites, and energy metabolism in vascular smooth muscle. Am J Physiol Heart Circ Physiol 267: H764-H769, 1994.
5. Barron JT and Parrillo JE. Production of lactic acid and energy metabolism in vascular smooth muscle: Effect of dichloroacetate. Am J Physiol Heart Circ Physiol 268: H713-H719, 1995.
6. Bayes-Genis A, Conover CA, and Schwartz RS. The insulin-like growth factor axis. A review of atherosclerosis and restenosis. Circ Res 86: 125-130, 2000.
7. Bouzier AK, Goodwin R, de Gannes FM, Valeins H, Voisin P, Canoni P, and Merle M. Compartmentalization of lactate and glucose metabolism in C6 glioma cells: A 13C and 1H NMR study. J Biol Chem 273: 27162-27169, 1998.
8. Brand FN, Abbott RD, and Kannel WB. Diabetes, intermittent claudication, and risk of cardiovascular events: The Framingham Study. Diabetes 38: 504-509, 1989.
9. Chatham JC, Bouchard B, and Des Rosiers C. A comparison between NMR and GCMS 13C-isotopomer analysis in cardiac metabolism (Abstract). J Mol Cell Cardiol 33: A19, 2001.
10. Chatham JC, Gao ZP, and Forder JR. Impact of 1 wk of diabetes on the regulation of myocardial carbohydrate and fatty acid oxidation. Am J Physiol Endocrinol Metab 277: E342-E351, 1999.
11. Comte B, Vincent G, Bouchard B, Jette M, Cordeau S, and Rosiers CD. A 13C mass isotopomer study of anaplerotic pyruvate carboxylation in perfused rat hearts. J Biol Chem 272: 26125-26131, 1997.
12. Dimitriadis G, Parry-Billings M, Bevan S, Dunger D, Piva T, Krause U, Wegener G, and Newshome EA. Effects of insulin-like growth factor I on the rates of glucose transport and utilization in rat skeletal muscle in vitro. Biochem J 285: 269-274, 1992.
13. Fujiwara R and Tsuguhiko N. Effects of glucose, insulin and insulin-like growth factor-I on glucose transport activity in cultured rat vascular smooth muscle cells. Atherosclerosis 127: 49-57, 1996.
14. Garcia MJ, McNamara PM, Gordon T, and Kannel WB. Morbidity and mortality in diabetics in the Framingham population: Sixteen year follow-up. Diabetes 23: 105-111, 1974.
15. Gibala MJ, Young ME, and Taegtmeyer H. Anaplerosis of the citric acid cycle: Role in energy metabolism of heart and skeletal muscle. Acta Physiol Scand 168:657-665, 2000.
16. Gibbons GH and Dzau VJ. Molecular therapies for vascular disease. Science 272: 689-693, 1996.
17. Grant MB, Wargovich TJ, Ellis EA, Tarnuzzer R, Caballero S, Estes K, Rossig M, Spoerri PE, and Pepine C. Expression of IGF-I, IGF-I receptor, and IGF binding proteins-1,-2,-3,-4, and -5 in human atherectomy specimens. Regul Pept 67: 137-144, 1996.
18. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234, 1998.
19. Hall JL, Chatham JC, Eldar-Finkelman H, and Gibbons GH. Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis. Role of GSK3beta. Diabetes 50: 1171-1.179, 2001.
20. Hall JL, Matter CM, Wang X, and Gibbons GH. Hyperglycemia inhibits vascular smooth muscle cell apoptosis: Mediator role of protein kinase C. Circ Res 87: 574-580, 2000.
21. Hardin CD and Finder DR. Glycolytic flux in permeabilized fresh isolated vascular smooth muscle cells. Am J Physiol Cell Physiol 274: C88-C96, 1998.
22. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, and Cortes P. Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96: 1802-1814, 1995.
23. Jessen ME, Kovarik TE, Jeffrey FM, Sherry AD, Storey CJ, Chao RY, Ring WS, and Malloy CR. Effects of amino acids on substrate selection, anaplerosis, and left ventricular function in the ischemic perfused rat heart. J Clin Invest 92: 831-839, 1993.
24. Jung F, Haendeler J, Goebel C, Zeiher AM, and Dimmeler S. Growth factor-induced phosphoinositide 3-OH kinase/Akt phosphorylation in smooth muscle cells: Induction of cell proliferation and inhibition of cell death. Cardiovasc Res 48: 148-157, 2000.
25. Kemp PR, Radda GK, and Seymour AL. Carbohydrate and amino acid metabolism in the A10 vascular smooth muscle cell line. Biochem Soc Trans 18: 661, 1991.
26. Klip A, Tsakiridis T, Marette A, and Oritz P. Regulation of expression of glucose transporters by glucose: A review of studies in vivo and in cell culture. FASEB J 8: 43-53, 1994.
27. Koya D and King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866, 1998.
28. Lynch RM and Paul RJ. Compartmentalization of glycolytic and glycogenolytic metabolism in vascular smooth muscle. Science 222: 1344-1346, 1983.
29. Lynch RM and Paul RJ. Energy metabolism and transduction in smooth muscle. Experientia 41: 970-977, 1985.
30. Mallet RT, Hartman DA, and Bunger R. Glucose requirement for postischemic recovery of perfused working heart. Eur J Biochem 188: 481-493, 1990.
31. 13C isotopomer analysis of glutamate. Am J Physiol Heart Circ Physiol 259: H987-H995, 1990.
32. Niskanen L, Turpeinen A, Penttilä I, and Uusitupa MI. Hyperglycemia and compositional lipopoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: A 15-year follow-up from the time of diagnosis. Diabetes Care 21: 1861-1869, 1998.
33. Peters-Wendisch PG, Kreutzer C, Kalinowski J, Patek M, Sahm H, and Eikmanns BJ. Pyruvate carboxylase from Corynebacterium glutaminicum: Characterization, expression and inactivation of the pyc gene. Microbiology 144: 915-927, 1998.
34. Peters-Wendisch PG, Schiel B, Wendisch VF, Katsoulidis E, Mockel B, Sahm H, and Eikmanns BJ. Pyruvate carboxylase is a major bottleneck for glutamate and lysine production by Corynebacterium glutamicum. J Mol Microbiol Biotechnol 3: 295-300, 2001.
35. Pisarenko OI, Solomatina ES, and Studneva IM. The role of amino acid catabolism in the formation of the tricarboxylic acid cycle intermediates and ammonia in anoxic rat heart. Biochim Biophys Acta 885: 154-161, 1986.
36. Prentki M. New insights into pancreatic beta-cell metabolic signaling in insulin secretion. Eur J Endocrinol 134: 272-286, 1996.
37. Ren JM, Marshall BA, Gulve EA, Gao J, Johnson DW, Holloszy JO, and Mueckler M. Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. J Biol Chem 268: 16113-16115, 1993.
38. Roberts TM, Sturek M, Dixon JL, and Hardin CD. Alterations in the oxidative metabolic profile in vascular smooth muscle from hyperlipidemic and diabetic swine. Mol Cell Biochem 217: 99-106, 2001.
39. Roche E, Farfari S, Witters LA, Assimacopoulos-Jeannet F, Thumelin S, Brun T, Corkey BE, Saha AK, and Prentki M. Long-term exposure of b-INS cells to high glucose concentrations increases anaplerosis, liopogenesis, and lipogenic gene expression. Diabetes 47: 1086-1094, 1998.
40. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 314:488-500, 1986.
41. Rumble JR, Cooper ME, Soulis T, Wu L, Youssef S, and Gilbert RE. Vascular hypertrophy in experimental diabetes: Role of advanced glycation end products. J Clin Invest 99: 1016-1027, 1997.
42. Russell RR III and Taegtmeyer H. Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate. J Clin Invest 87: 384-390, 1991.
43. Schuit F, De Vos A, Farfari S, Moens K, Pipeleers D, Brun T, and Prentki M. Metabolic fate of glucose in purified islet cells. Glucose -regulated anaplerosis in beta cells. J Biol Chem 272: 18572-18579, 1997.
44. Semsarian C, Sutrave P, Richmond DR, and Graham RM. Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model. Biochem J 339: 443-451, 1999.
45. Sonnewald U, Wang AY, Schousboe A, Erikson R, and Skottner A. New aspects of lactate metabolism: IGF-I and insulin regulate mitochondrial function in cultured brain cells during normoxia and hypoxia. Dev Neurosci 18: 443-448, 1996.
46. Stamler J, Vaccaro O, Neaton JD, and Wentworth D. Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434-444, 1993.
47. Standley PR and Rose KA. Insulin and insulin-like growth factor-1 modulation of glucose transport in arterial smooth muscle cells: Implication of GLUT-4 in the vasculature. Am J Hypertens 7: 357-362, 1994.
48. Vincent G, Comte B, Poirier M, and Rosiers CD. Citrate release by perfused rat hearts: A window on mitochondrial cataplerosis. Am J Physiol Endocrinol Metab 278: E846-E856, 2000.
49. Weiss RG, Kalil-Filho R, Herskowitz A, Chacko VP, Stern MD, and Gerstenblith G. Indexing tricarboxylic acid activity in postischemic rat hearts. Circulation 87: 270-282, 1993.
50. Zhu B, Zhao G, Witte DP, Hui DY, and Fagin JA. Targeted overexpression of IGF-I in smooth muscle cells of transgenic mice enhances neointimal formation through increased proliferation and cell migration after intraarterial injury. Endocrinology 142:3598-3606, 2001.